Narcan Program

0 views

Skip to first unread message

Kahlil Algya

unread,

Aug 3, 2024, 5:39:31 PM8/3/24

to pronthurssuraft

Drug overdose is a serious public health concern and opioid-related overdose has increased as a health threat. A life-saving law took effect on April 1, 2006, making it legal in New York State for non-medical persons to administer Naloxone to another individual to prevent an opioid/heroin overdose from becoming fatal. All registered opioid overdose programs are furnished Naloxone (Narcan) by the NYSDOH. It is a prescription medicine that reverses an overdose by blocking heroin (or other opioids) in the brain for 30 to 90 minutes.

Naloxone is a medication that can save lives by reversing the effects of an opioid overdose. Some examples of opioids are heroin, fentanyl, methadone, OxyContin, and Vicodin. You can give naloxone to someone as an injection or nasal spray.

The Statewide Standing Order to Dispense Naloxone can be used as a prescription for naloxone. People may take this standing order to a pharmacy to get naloxone instead of going to a health care provider to get a prescription. Organizations may also use this standing order to get naloxone.

Important: A law went into effect on January 1, 2022 that affects how Department of Health (DOH) can provide naloxone kits to your program. If you represent a Behavioral Health Agency (BHA) and/or Opioid Treatment Program (OTP), please see Reference Page for 2SSB 5195 or email naloxon...@doh.wa.gov to learn how this law applies to your agency.

The DOH Overdose Education and Naloxone Distribution (OEND) program supports access to naloxone for people who are likely to experience or witness an opioid overdose. The program provides free naloxone for distribution to clients and community members, overdose recognition and response trainings for community organizations, and technical assistance to organizations that are interested in distributing naloxone.

Naloxone is a safe and effective opioid overdose reversal medication that saves lives. The Illinois Department of Human Services, Division of Substance Use Prevention and Recovery (IDHS/SUPR) aims to reduce the number of opioid overdoses through the expansion of community-based Overdose Education and Naloxone Distribution (OEND) services. IDHS/SUPR manages the Drug Overdose Prevention Program (DOPP), as legislated in the Substance Use Disorder Act, which allows organizations to order free Narcan (a form of naloxone) through our Access Narcan program to distribute within their communities. These programs are essential to ending the overdose crisis in Illinois by making sure that anybody who may witness an opioid overdose is equipped with naloxone and the knowledge they need to save a life.

All organizations (except pharmacies) that use the Illinois Department of Public Health Naloxone Standing Order must enroll in DOPP. IDHS/SUPR encourages all other organizations to enroll even if they conduct OEND services under their own standing order.

If you are seeking no-cost naloxone for your first-aid kits or fentanyl/xylazine testing strips, there are funded OEND service organizations responsible for all counties who can provide these resources. OENDs can also provide larger quantities if the interested organization decides that they do not want to enroll in DOPP.

Please be aware that organizations must use organizational addresses for enrollment. If the organization is using a residential address, IDHS/SUPR is obligated by Minnesota law to inform you that the address is collected solely for the purpose of delivering naloxone. All addresses are used exclusively for this purpose. Residential addresses are not the preferred address for enrollment.

Access to this information is limited to the Substance Use Prevention and Recovery (SUPR) staff overseeing the Drug Overdose Prevention Program (DOPP) and Emergent, the entity managing the shipping database.

The purpose of this project is to encourage distribution of naloxone to people who use drugs, their friends and families, and the community members, but distribution can be limited to an organization's patients/clients/participants.

SUPR uses this data to report to our funder, the Substance Abuse and Mental Health Services Administration (SAMHSA). By consistently reporting this data, you are contributing to our efforts to meet goals, target areas in need, and ultimately help save lives.

It is recommended that you carry naloxone if you or a loved one are prescribed and/or use opioids. Illinois Public Act 099-0480 became effective September 9, 2015 as an enhancement to Illinois Public Act 096-0361, enabling nonmedical personnel to administer naloxone without liability. Anyone in Illinois can get trained to carry and administer naloxone. Most insurance will cover some or all of the cost of generic naloxone and/or Narcan brand naloxone nasal spray.

Illinois' Good Samaritan Law (PA-096-0361) took effect in 2010, making it legal in Illinois for non-medical persons to administer the drug overdose reversal medication Naloxone to another individual in order to prevent an opioid/heroin overdose from becoming fatal.

Due to the Statewide Naloxone Standing Order in Illinois, Naloxone is available at pharmacies and DOPPs. Contact the Illinois Helpline by chatting through their website, calling 1-833-234-6343, or texting "HELP" to 833234 to find a DOPP near you.

Individuals: In addition to accessing naloxone at their local pharmacy through the PA Department of Health's standing order, community members can request the medication at no cost through PA's statewide mail-to-home naloxone program.

A full listing of eligible and priority first responder groups is available in the FY 2022-23 NFRP Guidelines. Some examples of just a few of the kinds of eligible first responders who can receive kits through the NFRP are below:

County/Regional CCEs serve as the primary point of contact for first responders within their communities to request and receive naloxone at no cost. There are currently 48 County/Regional CCEs covering all 67 counties across the Commonwealth. Contact information for these CCEs is available in the interactive map on this webpage.

In addition to these designated County/Regional CCEs, PCCD has also designated a state-level allocation of naloxone to supplement county/regional distribution efforts. The Statewide NFRP Portal provides naloxone to eligible organizations looking to enhance their community-based distribution efforts, with a focus on reaching individuals with the greatest risk. These include, but are not limited to, the following populations:

Requests for naloxone through the NFRP's Statewide Naloxone Allocation must be made using a Statewide Naloxone Request Form. Applications from eligible organizations will be reviewed on a rolling basis, and naloxone will be distributed based on a formula adopted by the Pennsylvania Opioid Command Center's Statewide Naloxone Distribution Strategy Workgroup.

NOTE: First responders/organizations in need of naloxone should first reach out to their relevant County/Regional CCE directly prior to contacting PCCD and/or making a request for naloxone through PCCD's Statewide Naloxone Request Form.

In addition, PCCD has partnered with Prevention Point Pittsburgh, using a grant from the Bloomberg Philanthropies and Vital Strategies, to provide technical assistance and support to grassroots organizations seeking to start or expand community-based naloxone programs. If you are a grassroots organization interested in learning more about naloxone distribution strategies and how to access no-cost naloxone for your community, please reach out to Julia Hilbert (ju...@pppgh.org) at Prevention Point Pittsburgh.

On January 9, 2023, PCCD and DDAP announced the availability of up to $1.5 million in federal State Opioid Response (SOR) funds to support naloxone distribution efforts and improve naloxone saturation levels across the state. Active CCEs in good standing with PCCD are eligible to apply for up to $75,000 (total) under this solicitation to support proposed project activities over up to 18 months .

Naloxone, also known by the brand name Narcan, is a drug that can reverse the effect of an opioid or heroin overdose, and can be life-saving if administered in time. Naloxone can be given to anyone with symptoms of an opioid overdose.

To increase the amount of naloxone available in communities across Indiana, the Indiana Department of Health (IDOH) has used state and federal funds to provide naloxone to local health departments (LHDs). IDOH has generated several grant opportunities for its naloxone distribution program, in which LHDs were awarded and responsible for distributing the free doses and providing naloxone training within their communities. As of July 2021, six rounds of the distribution program have been completed, with a seventh round in progress. In its first round, the program distributed 3,473 doses of naloxone to 23 LHD participants. Since then, the program has distributed a total of 98,239 doses of naloxone to LHDs with round 6 having the largest number of participants at 54 and round 7 having the largest number of doses distributed at 27,644 (and still growing). The map below shows each county that has been involved in the program, color coded by how many rounds they have been involved. Since 2018, approximately 4.2 million dollars has been spent for the LHDs. Each year the amount of money spent on doses increases, as the need for doses also increases. Approximately $860,000 was spent on kits in the entirety of the 2018 calendar year, while approximately $1,400,000 has been spent in only half of the 2021 calendar year.

If you are a lay responder, i.e. a non-medical personnel who acts in an emergency, and would like to find out where to get naloxone naloxone, please visit optin.IN.gov and type in your zip code to find an entity near you.

To complement the distribution program, IDOH is targeting 49 rural counties that represent 1.47 million Indiana residents (22.3% of the total population). These counties have high rates of non-fatal emergency department visits due to opioid overdose and a lower reported use of naloxone by first responders. As part of this effort, the IDOH is also expanding the Indiana Recovery and Peer Support Initiative for referral to treatment.